About James Lousararian
Form D filings for Triopsy Medical from 2022 to 2024 list James Lousararian as director.
James Lousararian first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name James Lousararian in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people James Lousararian works with at each company, as listed on that company's latest Form D.
Triopsy Medical, Inc. · Form D, Feb 28, 2024
RL
Richard Larson
Director
DB
David Bostwick
Executive officer and director
Brad Buscher
Executive Chairman
JH
John Harper
Director
DW
Deborah Wittman
Director
MM
Michael Montag
Director